[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "702 514 4174", "website": "https://www.pasithea.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 75, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 46, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 480000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 345939, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Graeme  Currie Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 346617, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yassine  Bendiabdallah Ph.D.", "age": 39, "title": "COO & Head of UK Clinics", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.64, "open": 3.55, "dayLow": 3.26, "dayHigh": 3.59, "regularMarketPreviousClose": 3.64, "regularMarketOpen": 3.55, "regularMarketDayLow": 3.26, "regularMarketDayHigh": 3.59, "beta": 0.821, "forwardPE": -4.661972, "volume": 47380, "regularMarketVolume": 47380, "averageVolume": 934560, "averageVolume10days": 36110, "averageDailyVolume10Day": 36110, "marketCap": 3458652, "fiftyTwoWeekLow": 3.2, "fiftyTwoWeekHigh": 17.4, "fiftyDayAverage": 4.36566, "twoHundredDayAverage": 5.80791, "currency": "USD", "enterpriseValue": -4511661, "floatShares": 802648, "sharesOutstanding": 1044910, "sharesShort": 22799, "sharesShortPriorMonth": 419, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0218, "heldPercentInsiders": 0.23124, "heldPercentInstitutions": 0.02871, "shortRatio": 0.01, "shortPercentOfFloat": 0.0276, "bookValue": 15.492, "priceToBook": 0.21365866, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -16370943, "trailingEps": -14.79, "forwardEps": -0.71, "enterpriseToEbitda": 0.277, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "KTTA", "underlyingSymbol": "KTTA", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "firstTradeDateEpochUtc": 1631712600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f19ed9f9-de4f-3b85-b823-68e1246ae624", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.31, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 7967569, "totalCashPerShare": 7.631, "ebitda": -16274925, "quickRatio": 5.712, "currentRatio": 6.196, "returnOnAssets": -0.37903, "returnOnEquity": -0.6325, "freeCashflow": -9018887, "operatingCashflow": -14920285, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-11"}]